products to its list of drugs that are in short supply. The FDA said an increase in demand for the drug was driving the shortage.
A congressional report on the risks of drug shortages in the U.S. also pointed to manufacturing snags and other supply-chain disruptions, strong consumer demand, and overprescription by doctors as drivers of the shortages. Liquid forms of the drug, suitable for children who are too young to swallow pills, are in short supply, according to the FDA's list. They're manufactured by Teva Pharmaceuticals and other drug companies. of alternative antibiotic options for common pediatric conditions. If available, the best alternatives are other forms of amoxicillin, in tablet, capsule or in chewable form.
"Tablets can be split/crushed to mix with any liquid or semisolid, like applesauce. This can be given orally or by tube," according to the AAP.